Nutrition and cervical neoplasia

Cancer Causes and Control

Volumn 7, Issue 1, 1996, Pages 113-126

  Potischman, Nancy ^a   Brinton, Louise A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical cancer; Diet; Epidemiology; Human papillomavirus; Review

Indexed keywords

ASCORBIC ACID; CAROTENOID;

DIET; FEMALE; HUMAN; NUTRITION; PAPILLOMA VIRUS; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER;

ASCORBIC ACID; CAROTENOIDS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DEVELOPING COUNTRIES; DISEASE PROGRESSION; FEMALE; FOLIC ACID; HUMANS; NUTRITION PHYSIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PUBLIC HEALTH; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VITAMIN E;

EID: 0030049010     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00115643     Document Type: Review

References (80)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide frequency of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. Doll R, Peto R. The Causes of Cancer. Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. New York, NY (USA): Oxford University Press, 1981.
3. Schiffman MH, Brinton LA, Fraumeni JF Jr, Devesa SS. Cervical cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology. New York, NY (USA): Oxford University Press, in press.
4. zur Hausen H. Human Pathogenic Papillomaviruses. Heidelberg, Germany: Springer Verlag, 1994.
5. Franco EL. The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology 1991; 2: 98-106.
6. Schiffman MH. Validation of HPV hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. In: Muñoz N, Boxch FX, Shah KV, Meheus A, eds. The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon, France: IARC, 1992 IARC Sci. Pub. No. 119: 169-79.
7. Wright TC, Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm. Papillomavirus Report 1994; 5: 175-82.
8. Whitehead N, Reyner F, Lindenbaum J. Megaloblastic changes in the cervical epithelium: association with oral contraceptive therapy and reversal with folic acid. JAMA 1973; 226: 1421-4.
9. King JC, Bronstein MN, Ritch WL, et al. Nutrient utilization during pregnancy. World Rev Nutr Diet 1987; 52: 71-142.
10. Bosch FX, Muñoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 750-8.
11. Cuzick J,Terry G, Ho L, et al. Human papillomvirus type 16 DNA in cervical smears as a predictor of high-grade cervical intraepithelial neoplasia. Lancet 1992; 339: 959-69.
12. Muñoz N, Bosch FX, de Sanjose S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarker Prev 1993; 2: 423-31.
13. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: 114-9.
14. Hildesheim A, Schiffman MH, Gravitt P, et. al. Persistence of typespecific human papillomavirus infection among cytologically normal women in Portland, Oregon. J Infect Dis 1994; 169: 235-240.
15. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969; 105: 386-93.
16. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. JNCI 1968; 40: 43-68.
17. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617-31.
18. Kolonel LN, Hankin JH, Lee J, Chu SY, Nomura AMY, Hinds MW. Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 1981; 44: 332-9.
19. Marshall JR, Graham S, Byers T, Swanson M, Brasure J. Diet and smoking in the epidemiology of cancer of the cervix. JNCI 1983; 70: 847-51.
20. Brock KE, Berry G, Mock PA, MacLennan R, Truswell AS, Brinton LA. Nutrients in diet and plasma and risk of in situ cervical cancer. JNCI 1988; 80: 580-5.
21. La Vecchia C, Decarli A, Fasoli M, et al. Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecol Oncol 1988; 30: 187-95.
22. Verreault R, Chu J, Mandelson M, Shy K. A case-control study of diet and invasive cervical cancer. Int J Cancer 1989; 43: 1050-4.
23. Ziegler RG, Brinton LA, Hamman RF, et al. Diet and the risk of invasive cervical cancer among white women in the United States. Am J Epidemiol 1990; 132: 432-45.
24. Slattery ML, Abbott TM, Overall JC, et al. Dietary vitamins A, C, and E and selenium as risk factors for cervical cancer. Epidemiology 1990; 1: 8-15.
25. Herrero R, Potischman N, Brinton LA, et al. A case-control study of nutrient status and invasive cervical cancer: I. Dietary indicators. Am J Epidemiol 1991; 134: 1335-46.
26. de Vet HCW, Knipschild PG, Grol MEC, Scheuten HJA, Sturmans F. The role of beta-carotene and other dietary factors in the aetiology of cervical dysplasia: results of a case-control study. Int J Epidemiol 1991; 20: 603-10.
27. Ziegler RG, Jones CJ, Brinton LA, et. al. Diet and the risk of in situ cervical cancer among white women in the United States. Cancer Causes Control 1991; 2: 17-29.
28. Lambert B, Brisson G, Bielmann P. Plasma vitamin A and precancerous lesions of cervix uteri: A preliminary report. Gynecol Oncol 1981; 11: 136-9.
29. Harris RWC, Forman D, Doll R, Vessey MP, Wald NJ. Cancer of the cervix uteri and vitamin A. Br J Cancer 1986; 53: 653-9.
30. Palan PR, Romney SL, Mikhail M, Basu J, Vermund SH. Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer. JNCI 1988; 80: 454-5.
31. Palan PR, Mikhail MS, Basu J, Romney SL. Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 1991; 15: 13-20.
32. Cuzick J, De Stavola BL, Russell MJ, Thomas BS. Vitamin A, vitamin E and the risk of cervical intraepithelial neoplasia. Br J Cancer 1990; 62: 651-2.
33. Potischman N, Herrero R, Brinton LA, et al. A case-control study of nutrient status and invasive cervical cancer: II. Serologic indicators. Am J Epidemiol 1991; 134: 1347-55.
34. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993; 2: 335-9.
35. Meyskens FL Jr, Surwit E, Moon TE, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. JNCI 1994; 86: 539-43.
36. Linder MC. Nutrition and metabolism of vitamins. In: Linder MC, ed. Nutritional Biochemistry and Metabolism. New York, NY (USA): Elsevier Science Publishing Company, Inc. 1985: 69-131.
37. Palan PR, Mikhail MS, Basu J, Romney SL. β-carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia and cervical cancer. Am J Obstet Gynecol 1992; 167: 1899-903.
38. VanEenwyk J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 34-8.
39. Potischman N, Hoover RN, Brinton LA, et al. The relations between cervical cancer and serological markers of nutritional status. Nutr Cancer 1994; 21: 193-201.
40. Smith AH, Waller KD. Serum beta-carotene in persons with cancer and their immediate families. Am J Epidemiol 1991; 133: 661-71.
41. de Vet HCW, Knipschild PG, Willebrand D, Schouten HJA, Sturmans F. The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment.J Clin Epidemiol 1991; 44: 273-83.
42. Mackerras D, Baghurst P, Fairley C, Irwig L, Weisburg E, Simpson J. Beta-carotene and cervical dysplasia trials in Australia. Ann NY Acad Sci 1993; 691: 253-4.
43. Sankaranarayanan R, Wahrendorf J, Demaret E, eds. Directory of On-Going Research in Cancer Epidemiology. Lyon,France: International Agency for Research on Cancer, 1994; IARC Sci. Pub. No. 130: 408.
44. Wassertheil-Smoller S, Romney SL, Wylie-Rosett J, et al. Dietary vitamin C and uterine cervical dysplasia. Am J Epidemiol 1981; 114: 714-24.
45. Romney SL, Duttagupta C, Basu J, et al. Plasma vitamin C and uterine cervical dysplasia. Am J Obstet Gynecol 1985; 151: 976-80.
46. Basu J, Palan PR, Vermund SH, Goldberg GL, Burk RD, Romney SL. Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia. Cancer Detect Prev 1991; 15: 165-70.
47. VanEenwyk J, Davis FG, Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1992; 1: 119-24.
48. Knekt P. Serum vitamin E level and risk of female cancers. Int J Epidemiol 1988; 17: 281-6.
49. Stryker WS, Kaplan LA, Stein EA, Stampfer MJ, Sober A, Willett WC. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988; 127: 283-96.
50. Butterworth CE Jr, Hatch KD, Gore H, Mueller J, Krumdiek CL. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 1982; 35: 73-82.
51. Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 1985; 30: 145-55.
52. Butterworth CE Jr, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. JAMA 1992; 267: 528-33.
53. Potischman N, Brinton LA, Laiming VA, et al. A case-control study of serum folate levels and invasive cervical cancer. Cancer Res 1991; 51: 4785-9.
54. Butterworth CE Jr, Hatch KD, Soong S-J, et al. Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 1992; 166: 803-9.
55. Childers JM, Chu J, Voight LF, et al. Chemoprevention of cervical cancer with folic acid: A phase III Southwest Oncology Group Intergroup Study. Cancer Epidemiol Biomarkers Prev 1995; 4: 155-9.
56. Harper JM, Levine AJ, Rosenthal DL, et al. Erythrocyte folate levels, oral contraceptive use and abnormal cervical cytology. Acta Cytol 1994; 38: 324-30.
57. Amburgey CF, VanEenwyk J, Davis FG, et al. Undernutrition as a risk factor for cervical intraepithelial neoplasia: a case-control analysis. Nutr Cancer 1993; 20: 51-60.
58. Brock KE, Gridley G, Morris JS, Willett WC. Serum selenium level in relation to in situ cervical cancer in Astralia. JNCI 199;83:292-3.
59. Brock KE, Hoover RN, Hensley WJ. Plasma cholesterol and in situ cervical cancer: an Australian case-control study (Letter). J Clin Epidemiol 1989; 42: 87-9.
60. Hillemanns R, Tannous-Khuri L, Koulos JP, Talmage D, Wright TC Jr. Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Am J Pathol 1992; 141: 973-80.
61. Sizemore N, Rorke EA. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res 1993; 53: 4511-7.
62. Choo CK, Rorke EA, Eckert RL. Retinoid regulation of cell differentiation in a series of human papillomavirus type 16-immortalized human cervical epithelial cell lines. Carcinogenesis 1995; 16: 375-81.
63. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. II. Mechanisms. Cancer Causes Control 1991; 2: 427-42.
64. Di Mascio P, Murphy ME, Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols and thiols. Am J Clin Nutr 1991; 53: 195S-200S.
65. Henson DE, Block G, Levine M: Ascorbic acid: biologic functions and relation to cancer. JNCI 1991;83: 547-50.
66. Ascorbic acid: biologic functions and relation to cancer. Proceedings of a conference held at the National Institutes of Health, Bethesda, Md, September 10-12, 1990. Am J Clin Nutr 1991; 54(6 Suppl): 1113S-327S.
67. Ascorbic acid: biologic functions and relation to cancer. Proceedings of a conference held at the National Institutes of Health, Bethesda, Md, September 10-12, 1990. Am J Clin Nutr 1991; 54(6 Suppl): 1113S-327S.
68. Herbert V, Das KC. Folic acid and vitamin B12. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease. 8th Edition. Phildelphia, PA (USA): Lea & Febiger, 1994: 402-25.
69. Krumdieck CL. Role of folate deficiency in carcinogenesis. In: Butterworth CE, Hutchinson ML, eds. Nutrition Factors in the Induction and Maintenance of Malignancy. New York, NY (USA): Academic Press, 1983: 225-45.
70. Eto I, Krumdeick CL. Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exptl Med Biol 1986; 206: 313-30.
71. Butterworth CE Jr. Effect of folate on cervical cancer. Synergism among risk factors. Ann NY Acad Sci 1992; 669: 293-99.
72. Tindle RW, Frazer IH. Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. In: zur Hausen H, ed. Human Pathogenic Papillomaviruses. Hiedelberg, Germany Springer Verlag, 1994: 217-54.
73. Blumberg JB. Vitamins. In: Forse RA, Bell SJ, Blackburn GL, Kabbash LG, eds. Diet, Nutrition and Immunity. Boca Raton, FL (USA): CRC Press, 1994: 237-46.
74. Frei B, Stocker R, Ames B. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 1988; 85: 9748-52.
75. Bendich A. Carotenoids and immunity. Clin Appl Nutr 1991; 1: 45-51.
76. Randall E, Marshall J, Graham S, Brasure J. Frequency of food use data and the multidimensionality of diet. J Am Diet Assoc 1989; 89: 1070-5.
77. Patterson RW, Haines PS, Popkin BM. Diet quality index: capturing a multidimensional behaviour. J Am Diet Assoc 1994; 94: 57-64.
78. Wacholder S. When measurement errors correlate with truth: surprising effects of nondifferential misclassification. Epidemiology 1995; 6: 157-61.
79. Basu J, Mikhail MS, Goldberg GL, Palan PR, Romney SL. Measurement of ascorbic acid and glutathione in exfoliated cervicovaginal epithelial cells of smokers and women with cervical dysplasias. Gynecol Obstet Invest 1990; 30: 48-51.
80. Basu J, Mikhail MS, Payraudeau PH, Palan PR, Romney SL. Smoking and the antioxidant ascorbic acid: plasma, leukocyte, and cervicovaginal cell concentrations in normal healthy women. Am J Obstet Gynecol 1990: 163: 1948-52.